Resultados de la búsqueda 31-40 of 2631 for Inhibition

  1. Bloqueantes de los receptores de la angiotensina II - Mayo Clinic

    Major side effects of angiotensin-converting enzyme inhibitors and ... Renin-angiotensin system inhibition in the treatment of hypertension. https ...

  2. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    ... inhibitor. In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... inhibition. We hypothesize that targeting melanoma with a PD-1 (MC9324) CAR TIL therapy would capitalize on the tumor homing machinery of the TIL to drive ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  6. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    ... inhibitor. In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Olaparib is an inhibitor of PARP, an enzyme that helps repair ... PARP inhibitors are a type of targeted therapy. Adding abemaciclib to ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Olaparib is an inhibitor of PARP, an enzyme that helps repair ... PARP inhibitors are a type of targeted therapy. Adding abemaciclib to ...

  10. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. GENetic Risk Estimation of ...